Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B

NCT01926288 is registered in ClinicalTrials.gov with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. as lead sponsor.

NCT NCT01926288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01926288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B
Lead sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2008
Completion date
March 31, 2014
Enrollment
287 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b